Champions Oncology CSBR Stock
Champions Oncology Price Chart
Champions Oncology CSBR Financial and Trading Overview
| Champions Oncology stock price | 5.81 USD |
| Previous Close | 5.81 USD |
| Open | 6.16 USD |
| Bid | 4.35 USD x 200 |
| Ask | 7.61 USD x 200 |
| Day's Range | 5.82 - 6.16 USD |
| 52 Week Range | 5.5 - 8.74 USD |
| Volume | 2.46K USD |
| Avg. Volume | 8.33K USD |
| Market Cap | 80.82M USD |
| Beta (5Y Monthly) | 0.389 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CSBR Valuation Measures
| Enterprise Value | 78.79M USD |
| Trailing P/E | N/A |
| Forward P/E | 58.2 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.3947939 |
| Price/Book (mrq) | 18.896105 |
| Enterprise Value/Revenue | 1.36 |
| Enterprise Value/EBITDA | -102.057 |
Trading Information
Champions Oncology Stock Price History
| Beta (5Y Monthly) | 0.389 |
| 52-Week Change | -26.97% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 8.74 USD |
| 52 Week Low | 5.5 USD |
| 50-Day Moving Average | 6.04 USD |
| 200-Day Moving Average | 6.34 USD |
CSBR Share Statistics
| Avg. Volume (3 month) | 8.33K USD |
| Avg. Daily Volume (10-Days) | 7.75K USD |
| Shares Outstanding | 13.89M |
| Float | 6.07M |
| Short Ratio | 11.29 |
| % Held by Insiders | 26.67% |
| % Held by Institutions | 41.36% |
| Shares Short | 76.92K |
| Short % of Float | 1.12% |
| Short % of Shares Outstanding | 0.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | April 30, 2026 |
Profitability
| Profit Margin | -4.043% |
| Operating Margin (ttm) | -1.12% |
| Gross Margin | 45.87% |
| EBITDA Margin | -1.33% |
Management Effectiveness
| Return on Assets (ttm) | -4.70% |
| Return on Equity (ttm) | -47.58% |
Income Statement
| Revenue (ttm) | 57.95M USD |
| Revenue Per Share (ttm) | 4.2 USD |
| Quarterly Revenue Growth (yoy) | -2.80% |
| Gross Profit (ttm) | 26.58M USD |
| EBITDA | -772000 USD |
| Net Income Avi to Common (ttm) | -2343000 USD |
| Diluted EPS (ttm) | -0.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.13M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 5M USD |
| Total Debt/Equity (mrq) | 114.19 USD |
| Current Ratio (mrq) | 0.976 |
| Book Value Per Share (mrq) | 0.308 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.39M USD |
| Levered Free Cash Flow (ttm) | 4.7M USD |
Profile of Champions Oncology
| Country | United States |
| State | NJ |
| City | Hackensack |
| Address | One University Plaza |
| ZIP | 07601 |
| Phone | 201 808 8400 |
| Website | https://www.championsoncology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 213 |
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Q&A For Champions Oncology Stock
What is a current CSBR stock price?
Champions Oncology CSBR stock price today per share is 5.81 USD.
How to purchase Champions Oncology stock?
You can buy CSBR shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Champions Oncology?
The stock symbol or ticker of Champions Oncology is CSBR.
Which industry does the Champions Oncology company belong to?
The Champions Oncology industry is Biotechnology.
How many shares does Champions Oncology have in circulation?
The max supply of Champions Oncology shares is 13.89M.
What is Champions Oncology Price to Earnings Ratio (PE Ratio)?
Champions Oncology PE Ratio is now.
What was Champions Oncology earnings per share over the trailing 12 months (TTM)?
Champions Oncology EPS is -0.18 USD over the trailing 12 months.
Which sector does the Champions Oncology company belong to?
The Champions Oncology sector is Healthcare.
Champions Oncology CSBR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25873.18 USD — |
-1.55
|
6.31B USD — | 25822.1 USD — | 26139.37 USD — | — - | 6.31B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31918 USD — |
-1.55
|
— — | 31854.98 USD — | 32246.38 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
138.78 USD — |
-2.69
|
— — | 138.28 USD — | 141.36 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1254.95 USD — |
-1.05
|
— — | 1250.11 USD — | 1262.34 USD — | — - | — — |
- {{ link.label }} {{link}}